Histologic classification of ampullary carcinomas as intestinal versus pancreatobiliary is rapidly becoming a part of management algorithms, with immunohistochemical classification schemes also being devised using this classification scheme as their basis. However, data on the reproducibility and prognostic relevance of this classification system are limited. In this study, five observers independently evaluated 232 resected ampullary carcinomas with invasive component 43 mm. Overall interobserver agreement was 'fair' (κ 0.39; Po0.001) with complete agreement in 23%. Using agreement by 3/5 observers as 'consensus' 40% of cases were classified as 'mixed' pancreatobiliary and intestinal. When observers were asked to provide a final diagnosis based on the predominant pattern in cases initially classified as mixed, there was 'moderate' agreement (κ 0.44; Po0.0001) with 5/5 agreeing in 35%. Cases classified as pancreatobiliary by consensus (including those with pure-pancreatobiliary or mixed-predominantly pancreatobiliary features) had shorter overall (median 41 months) and 5-year survival (38%) than those classified as pure-intestinal/mixed-predominantly intestinal (80 months and 57%, respectively; P = 0.026); however, on multivariate analysis this was not independent of established prognostic parameters. Interestingly, when compared with 476 cases of pancreatic ductal adenocarcinomas, the pancreatobiliary-type ampullary carcinomas had better survival (16 versus 41 months, Po0.001), even when matched by size and node status. In conclusion, presumably because of the various cell types comprising the region, ampullary carcinomas frequently show mixed phenotypes and intratumoral heterogeneity, which should be considered when devising management protocols. Caution is especially warranted when applying this histologic classification to biopsies and tissue microarrays. While ampullary carcinomas with more pancreatobiliary morphology have a worse prognosis than intestinal ones this does not appear to be an independent prognostic factor. However, pancreatobiliary-type ampullary carcinomas have a much better prognosis than their pancreatic counterparts.
The ampulla of Vater is composed of multiple cell types. The duodenum-facing surface is covered partially by intestinal-type epithelium, which transitions into a specialized epithelium (of gastric foveolar type with intermixed goblet cells) at the 'papilla', and, on the wall, there resides 'pancreatobiliary-type' ductules, which show morphologic characteristics of pancreatobiliary ducts but also often express the intestinal transcription factor caudal-type homeobox 2 (CDX2).
It has long been noted that the carcinomas arising in this region may resemble colonic or pancreatobiliary adenocarcinomas, and are presumed to carry with them the prognostic stigmata associated with these carcinoma types, which for the former are relatively indolent, but highly dismal for the latter. Accordingly, a cell-lineage-based classification scheme has been proposed for these tumorspancreatobiliary and intestinal. [1] [2] [3] In fact, this has spawned several newly designed and revised treatment protocols with many oncologists now requiring and utilizing this classification for management purposes.
Recently, immunohistochemical panels have been proposed in an attempt to further substantiate this classification. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] However, in each of these immunohistochemical studies, different and sometimes complex combinations of markers have been advocated, many of which are arbitrarily defined, 4, 5, 7, 9, 11, 13, [16] [17] [18] [19] with their primary validation using histomorphologic classification as the 'gold standard'. Furthermore, many of these immunohistochemical markers are not widely available for use in community practice in the United States and in many parts of the world (at least not yet). Additionally, there are some problems in some of the immunohistochemical panels that have been used. For example, the protocols that have received the most attention utilize markers like CDX2 and CK20 to help establish intestinal lineage but several studies have recently shown that these markers can in fact be expressed, not uncommonly, by pancreatobiliary adenocarcinomas, as well as the pancreatobiliarytype ductules in this region, albeit often more focally. 4, 7, 20, 21 This further complicates the commonly mixed/hybrid nature of ampullary tumors which has been highlighted as a frequent finding in some studies. 22 Thus, it is not surprising that even with the most complex immunohistochemical panels devised to capture most cases 4,5 a significant proportion (18-39%) remain unclassifiable. 4, 5, 7, 9, 11, 13, [16] [17] [18] [19] While immunohistochemical protocols are being refined and verified for routine use, histomorphologic classification remains standard of care and is required by the College of American Pathologists' protocols. While this classification appears in theory to be simple and logical, its reproducibility, prognostic relevance and applicability to routine practice have not been fully tested, with conflicting results in the literature. 4, [7] [8] [9] [15] [16] [17] [18] 23 The purpose of this study was to verify the applicability and reproducibility of the morphologic classification of ampullary carcinomas and their clinical associations.
Materials and methods
The study was performed in accordance with the institutional review board requirements.
Case Selection
Among 1469 pancreatoduodenectomy specimens from the archives of the authors' pathology departments, 249 consecutive, stringently defined cases of invasive ampullary carcinoma (with a frequency of 17%, similar to that of most major studies) [24] [25] [26] [27] were culled.
Tumors were classified as ampullary carcinomas according to recently refined definitions. 6 Briefly, if its epicenter was located in the ampulla/major papilla, and if it fulfilled one of the four recognized categories, 6 which represents a modification of the four groups by the College of American Pathologists' cancer synoptic protocol for ampullary tumors 28 , then it was classified as an ampullary cancer. If more than 75% of the tumor was away from the ampulla, it was regarded as non-ampullary. All non-ampullary cancers and other dubious cases were excluded from analysis.
Of the 249 cases, only 232 tumors had complete material and foci of invasion that were 43.0 mm available for evaluation and these were selected for histologic subtyping. The 3.0 mm cutoff was selected to allow for adequate appreciation of the tumors' morphologic characteristics. Detailed anatomic sitespecific classification as well as some of the other clinicopathologic associations of this cohort was the subject of a previously published study and the morphologic classification that was done in that study was performed by a single author (VA), and was not based on consensus. 6 
Cell Lineage Morphology Assessment
Five pathologists blindly and independently classified the 232 invasive ampullary adenocarcinomas based on their resemblance to pancreatic/biliary or colonic carcinomas in accordance with the criteria proposed by Kimura et al 2 and endorsed by AlboresSaavedra et al 1 for ampullary carcinomas (Figure 1 ). The observers were from variable backgrounds (one fellow, one GI fellowship-trained, three generalist/ oncologic pathologists), all trained at different institutions and all working at different institutions at the time of the study, but all with interest/ expertise in pancreatobiliary/gastrointestinal and ampullary pathology.
Observers were instructed to acknowledge even a small component of a different cell lineage in any area of the invasive carcinoma including at the tumor's advancing edge. This was felt to be necessary and important, considering that the pancreatobiliary versus intestinal classification is now also advocated (and in fact, expected by oncologists) even for ampullary biopsies, and moreover, several immunohistochemical studies on this topic are based on tissue microarrays. 5, 8, 9, 13, 14, 29 Accordingly, in a 'purist approach' the observers were asked to classify each case into one of four categories as pure-intestinal, pure-pancreatobiliary, mixed pancreatobiliary-intestinal, or other (non-tubular (non-gland forming) adenocarcinoma; signet ring cell, neuroendocrine, undifferentiated, mucinous, and undetermined/unclassified cases that did not fit into any of the aforementioned three categories).
Separately, a forced-binary approach was then also applied for the mixed category of cases, where observers were asked to place the cases that they classified as 'mixed pancreatobiliary-intestinal' into either intestinal-predominant, pancreatobiliary-predominant, or predominantly non-glandular categories (Table 1) . This also applied to the 'other' category in that if the tumors showed predominant pancreatobiliary or intestinal tubular pattern, they were to be placed into the corresponding pancreatobiliary-or intestinal-predominant category.
For the purposes of correlation with clinicopathologic findings and clinical outcome, three of five agreements were considered a consensus diagnosis ( Table 2) .
After blinded review, the cases were re-analyzed by the observers as a group in an attempt to determine potential reasons or explanations for lack of concordance in classification.
Evaluation of Clinicopathologic Associations
Information on the patients' demographics, clinical presentation, and follow-up were obtained through pathology databases, patients' charts, and/or by contacting the patients' primary physicians.
Histologic grade, lymph-vascular, and perineural invasion, as well as lymph node and resection margin status were verified by histologic examination. Site-specific classification of the tumors as ampullary-duodenal, intra-ampullary papillary tubular neoplasm (IAPN)-associated, ampullary-ductal and ampullary-NOS (papilla of Vater) was performed as previously outlined. 6 Tumor budding was also measured and classified as low and high by using criteria previously outlined by Ohike et al. 30 The study was not controlled for patient treatment/management. However, there was also no known treatment bias employed in patient management.
Comparison of Pancreatobiliary-Predominant Group with Pancreatic Ductal Adenocarcinomas
The survival of the pancreatobiliary-predominant group of ampullary carcinomas was contrasted with a previously unpublished, cohort of 476 pancreatic ductal adenocarcinomas (pancreatobiliary-type carcinomas of pancreatic origin) from the authors' database.
Statistical Analysis
Descriptive data analyses were performed by calculating frequency and percentage for categorical variables, or measures of central tendency (means or medians) for continuous variables. After having checked for the normality assumption, the univariate analyses of continuous variables were done by one way analysis of variance or Kruskal Wallis tests, where it is appropriate. Tukey HSD or ConoverDunn tests were also used for multiple comparisons. For the univariate analyses of categorical variables, χ 2 tests were performed. Survival analyses examined factors associated with post-diagnosis mortality. Kaplan-Meier survival curves were constructed with corresponding log-rank tests for statistical significance to examine survival based on a variety of demographic and disease-related characteristics. Cox proportional hazards models and extended Cox models were utilized to estimate univariate and multivariate survival, when the proportional hazards assumption was violated, to examine the association between survival and a variety of factors taken together. Survival analysis results were expressed as hazard ratios (HRs) and reported with corresponding 95% confidence intervals (CIs). Proportional hazard assumptions were tested by examining log minus log plots for each variable in the model. In addition, all models were examined for interactions and multicolinearity among covariates. For all tests a two-sided Po0.05 was considered statistically significant. 
Results

Clinical Characteristics
For this cohort of 232 ampullary carcinomas with invasive component43.0 mm available for examination, the mean patient age was 65 years (range: 27-88 years) with a male to female ratio of 1.5:1. The mean tumor size was 2.6 cm (range 0.7-8.0 cm). Pathologic T-stage distribution was as follows: T1/T2/T3/T4, n = 58/86/83/5, respectively, with 40% of patients showing lymph node metastasis.
Histologic analysis # 1. There were 194 (84%) tubular (gland forming) carcinomas and 38 (16%) non-tubular or 'other' types of carcinoma. Using the 'purist' approach to classification (with the cases classified as pure-intestinal, pure-pancreatobiliary, mixed pancreatobiliary-intestinal, or other) the degree of interobserver agreement of the morphologic classification system was 'fair' (κ = 0.39; z = 28.80; P o 0.001). There was full agreement by all observers (5/5) in 53 cases (23%). Utilizing three of five agreements as consensus the frequencies of the four subtypes were as follows: Mixed pancreatobiliary-intestinal was the most common category (n = 94, 40%), followed by pure-pancreatobiliary (n = 74, 32%), other (n = 51, 22%), and pureintestinal (n = 13, 6%) ( Table 2 ).
Histologic analysis # 2. This analysis was performed by incorporating the results of the forcedbinary approach with each mixed case (and if applicable, 'other' cases) being classified as either mixed-intestinal or mixed pancreatobiliary based on the favored overall/predominant pattern. For analysis, the mixed-intestinal cases were grouped together with the pure-intestinal cases as intestinal-predominant, while the pure-pancreatobiliary and mixed pancreatobiliary cases were grouped together as pancreatobiliary-predominant. The level of interobserver agreement with this re-grouping improved to 'moderate' (κ = 0.44; z = 28.09; P o 0.0001) and the agreement between observers increased to 81 cases (35%). Utilizing three of five agreements as consensus the frequencies of the three subtypes were as follows: pancreatobiliary-predominant group (n = 137, 59%), intestinal-predominant group (n = 57, 25%), followed by the other group (n = 38, 16%) ( Table 2) .
Reasons for Discrepancies
In discussions held among the observers in order to elicit possible reasons for discrepancies, the following issues were elucidated: Of the mixed pancreatobiliary-intestinal tumors (n = 94), some cases showed transformative features characterized by a transition from intestinal-type epithelium on the one hand to pancreatobiliary-type epithelium, the latter sometimes detected at the leading edge of the invasive focus. Occasional mixed pancreatobiliary-intestinal cases also showed a composite pattern in the central part (and not the advancing edge) of the tumor with very distinct intestinal and pancreatobiliary patterns, but without predominance of any one component ( Figure 2) ; in others, the lining epithelium of the glands appeared to have chimeric features, that is, some features were attributable to intestinal and others to pancreatobiliary type morphology ( Figure 3 ).
Correlation of Morphologic Patterns with Clinicopathologic Characteristics
Purist's pattern groups. Utilizing the consensus diagnosis (3/5 agreement) in the purist's approach diagnoses (pure-pancreatobiliary, pure-intestinal, and mixed pancreatobiliary-intestinal), the comparison of clinicopathologic characteristics revealed that pure-intestinal-type tumors were largest (4.5 cm) compared with mixed pancreatobiliaryintestinal (2.7 cm) and pure-pancreatobiliary type (2.2 cm), and this was statistically significant (P o 0.001). The median survival of the pure-intestinal type was longer than the pure-pancreatobiliary type, 80 versus 40 months, but this was not statistically significant (P = 0.33) nor was the difference between pure-pancreatobiliary, mixed pancreatobiliary-intestinal, and pure-intestinal types (40 versus 56 versus 80 months, P = 0.65) (Figure 4 ). All other clinicopathologic characteristics (including nodal status, T stage, as well as 3-and 5-year survival rates) were also not statistically significant (Table 3) . At the same time, it was noted that the features of the mixed tumors fell between pureintestinal and pure-pancreatobiliary tumors in all characteristics including survival; however the median survival (56 months) was closer to that of pure-pancreatobiliary tumors (40 months) than pureintestinal tumors (80 months). The 'others' category was disregarded for this analysis.
Predominant pattern groups. On comparison of clinicopathologic characteristics of the consensus diagnosis based on the forced-binary approach (dividing the mixed pancreatobiliary-intestinal cases into pancreatobiliary-predominant or intestinalpredominant groups), multiple clinicopathologic characteristics were found to have a statistically significant association (Table 4) . Although pancreatobiliary-predominant tumors were smaller than the intestinal-predominant ones (mean 2.2 versus 3.6 cm) they had a higher pathologic T (pT3 +T4) stage at diagnosis (39% versus 21%, P o 0.05) and significantly shorter median survival of 41 versus 80 months (P = 0.026), shorter 3-year survival of 55% versus 75% (P o 0.05), and shorter 5-year survival of 38% versus 57% (P o 0.05) ( Table 4 and Figure 4 ) with a 1.78 times higher risk of death (95% CI: 1.06-2.98, P = 0.028).
In multivariate analysis, while high tumor budding, high T stage, and lymph node positivity remained independent prognostic factors (P o 0.05, respectively), histologic classification based on predominant histologic type (pancreatobiliary versus intestinal) failed to attain significance as an independent factor (P = 0.39).
Comparison of Ampullary Carcinoma with Conventional Pancreatic Ductal Adenocarcinoma
When the pancreatobiliary-predominant invasive ampullary carcinomas (n = 137) were compared with a well-characterized cohort of pancreatobiliary-type carcinomas of pancreatic ductal origin (n = 476), there was a statistically significant difference in survival between the two, with the pancreatic ones 22 more than 30% of invasive ampullary carcinomas in each category showed an unexpected, inverse immunoprofile. This is not surprising considering the transitional nature of this anatomic landmark, which is comprised of a variety of cell types, where even the normal constituent structures exhibit hybrid characteristics (eg, pancreatobiliarytype ducts on the ampullary wall often show CDX2 positivity). Accordingly, while conducting this study, it became clear that there is frequent and striking heterogeneity in the histologic phenotype of invasive ampullary carcinomas. Histomorphologic classification of ampullary carcinomas is expected in every case and is a requirement by the College of American Pathologists' synoptic reporting guidelines. Immunohistochemical support for this has promise but needs more detailed analysis. Interpretation of well-characterized antibodies may prove more objective than evaluating more subtle histopathologic parameters in many cases; however, the significance of that antibody expression, its correlation with cell lineage, and relationship to tumor biology are a totally different matter. Whether the markers used for this purpose will bring that kind of 'objectivity' to the classification of ampullary cancers is so far debatable as preliminary results by Costigan et al 31 indicate. While these immunohistochemical panels are being perfected, and until they become more applicable worldwide, morphologic classification of ampullary carcinoma will likely remain the norm. This study will hopefully allow the community to appreciate that a significant proportion of these tumors has hybrid features, thus alleviating some of the misconceptions that recent immunohistochemistrybased publications have inadvertently caused. This confusion is understandable since many of these studies now claim that immunohistochemistry validates classification, and has prognostic significance. Some now mistakenly conclude that tumor typing is highly applicable and oncologists are now not only demanding the classification but expect a specific answer in each and every case, unwilling to accept that some cases may be unclassifiable. Meanwhile, our study has shown that 40% of ampullary carcinomas are in fact mixed/hybrid by morphology, a figure that is much higher than, admittedly, even we had expected.
When these discrepant and 'mixed' cases were reanalyzed to investigate possible reasons for the lack of clearcut agreement or distinction, it was elucidated that the hybrid nature of ampullary cancers can manifest in different ways; in some, this is attributable to different zones of the tumor exhibiting distinctive morphologic patterns, especially small tubular units with different cytomorphology within the tumor's advancing edge. In others, the tumor cells within the same region (ie, same glands) appeared chimeric, showing some features resembling intestinal and others resembling more pancreatobiliary lineage. In such cases, depending on which criterion/feature an observer relied upon more heavily, the favored (predominant) pattern varied. Of note, the preinvasive component of even the purepancreatobiliary tumors often appears to be of intestinal phenotype as also previously noted in detail, 22 and in fact, may be the reason why some recent publications have differing results.
Regardless of mechanism, this heterogeneity impedes the ability of pathologists to accurately classify these tumors in some cases, even on full-face tissue sections, a problem that is naturally compounded in small biopsies. For this reason, histologic typing of ampullary carcinomas in endoscopic or image-guided biopsies should be regarded as preliminary and is subject to change after examination of the entire tumor. Furthermore, the results of immunohistochemical studies that utilize tissue microarrays prepared from a limited amount of tumor cells ought to be evaluated with caution, and in fact, may have to be avoided if a more 'complete' picture of the tumor is intended. It should be noted here that tissue microarray-based studies also suffer from the challenge of determining whether the fragment being analyzed represents a preinvasive or invasive tumor component. Some of the advocated immunohistochemical panels are proving complex and expensive and may not have the presumed prognostic value (unpublished personal data). For example, some of the clinician-driven studies including those by Schueneman et al 13 (a microarray-based study) and Chang et al 5 appeared to have included in situ carcinomas and adenomas in their analysis. Hence, it is not surprising that the latter studies give the impression of a prognostic correlation since most adenomas are CDX2+/MUC1 − and have a much better prognosis than invasive carcinomas. Our main aim in this study was to assess the applicability and reproducibility of morphologic classification of ampullary carcinoma for the purposes of current daily practice and future studies that will attempt to use this classification as the basis to develop more discriminatory immunohistochemical panels. In fact, in this study, during the selection of cases for analysis, it became clear that distinguishing preinvasive from invasive neoplasms in the ampulla can be very challenging, with mimicry both ways, as has been previously highlighted by others. 32 This phenomenon (preinvasive and invasive components often showing different phenotypes) 22 may have also influenced the results of some studies. 5, 8, 9, 19 While our study highlights several challenges in the applicability of histologic typing of ampullary carcinomas as pure-intestinal or pure-pancreatobiliary in routine practice, it also illustrates, based on the analysis of diagnoses rendered by the forcedbinary approach, that as a general group, intestinalpredominant tumors have different characteristics from 'pancreatobiliary-predominant' tumors, which is in accordance with the impression in the literature. [4] [5] [6] [11] [12] [13] [14] [17] [18] [19] [33] [34] [35] Pure-intestinal or intestinal-predominant ampullary carcinomas were significantly larger than their pancreatobiliary counterparts, but despite this, were less aggressive (with a tendency for lower stage disease, lower rates of nodal metastasis, and longer overall survival) than purepancreatobiliary or pancreatobiliary-predominanttype tumors, and almost double 5-year survival rate (38 versus 57%). However, on multivariate analysis this was not independent of other conventional pathologic parameters. In daily clinical practice one should be mindful that although the general characteristics of the groups differ significantly, this unfortunately does not mean that it is applicable to individual cases especially considering it is not independent prognostically. Interestingly, our cohort showed a relatively high frequency of pancreatobiliary-predominant cases, which is one reason we felt obliged to compare our cohort with pancreatic adenocarcinomas, and found that even the pancreatobiliary-predominant ampullary carcinomas had a much better prognosis than pancreatic adenocarcinomas. Nevertheless, the high frequency of the 'pancreatobiliary' type raises the question of possible bias in our criteria for histologic classification. Considering that all five observers at the time of this study had already trained and were working at different institutions this seems an unlikely contributor. One potential bias in our study may be the fact that all five observers had an interest in pancreatobiliary pathology and may thus have been prone to recognizing histologic patterns as 'pancreatobiliary'. However, these same observers were also heavily involved in, and exposed to, lower gastrointestinal tract pathology as well. Lastly, populational differences in the frequency of the pancreatobiliary-predominant pattern may account for differences in our cohort versus others. On the other hand, Costigan et al 31 from Ireland recently noted a similarly higher rate of pancreatobiliary-type ampullary carcinomas (65 and 50% by immunohistochemistry and histomorphology, respectively) in their cohort. 31 Analysis of larger cohorts with proper pathologic verification by multiple observers is required to better explain these differences.
The fact that the distinction between pancreatobiliary and intestinal-type ampullary carcinoma is fraught with challenges has significant implications for clinical management. Oncologists are now demanding that pathologists classify these tumors as such, and based on pathologic diagnoses will use gemcitabine-based treatment regimens for pancreatobiliary-type tumors and fluorouracil-based ones for intestinal-type tumors, often with conflicting or disappointing results. [36] [37] [38] [39] [40] [41] In the meantime, careful scrutiny of the literature suggests that the recently devised immunohistochemical panels in fact show vastly conflicting results, 4, 5, 7, 9, 11, 14, 15, [17] [18] [19] 21, 33 presumably a magnified reflection of the imperfections of morphologic classification as elucidated in this study. This is now also being observed in molecular studies, which have shown overlapping molecular alterations even in seemingly 'unambiguous' cases. 29, 42, 43 Nonetheless, we believe that in each case an attempt should be made to determine the predominant/favored histologic type and advocate diagnosing such cases, for example, as 'invasive ampullary adenocarcinoma, tubular type, with mixed/hybrid pattern, predominantly with pancreatobiliary or intestinal-type features'. Of note, we do not currently officially incorporate immunohistochemistry results in our classification.
This study also demonstrates the importance of classifying ampullary cancers separately from pancreatic carcinomas. Several studies on this topic suggest that in periampullary tumors the site of origin (pancreatic or ampullary) is not a significant prognostic predictor, and that histologic tumor typing alone (as pancreatobiliary versus intestinal) may suffice. 14, 33, 35, 44 Some authors have even questioned whether ampullary carcinoma should even be regarded as a separate entity when classifying these tumors. 23, 35 Our study documents, firstly, that the pancreatobiliary variant of ampullary cancers are seldom pure (unlike pancreatic ductal adenocarcinoma and common bile duct carcinomas which are almost always pure), and second, and far more importantly, even the pancreatobiliary-type ampullary cancers have a much better prognosis than pancreatobiliary carcinomas arising in the pancreas. Thus, histologic typing and primary site of the tumor ought to be evaluated and reported separately.
In conclusion, as a transitional region, carcinomas of the ampulla often show hybrid phenotypes between pancreatobiliary and intestinal epithelium, which cause substantial subjectivity in their histologic designation. Mixed carcinomas with intratumoral heterogeneity are a frequent finding. If morphologic classification is done based on a predominant pattern approach, the histologic pancreatobiliary versus intestinal classification has moderate agreement, significant clinical associations, and a good prognostic value; however, the difference in survival is by no means analogous to that of pancreatic versus colonic adenocarcinoma. On the other hand, our findings also confirm that ampullary carcinomas should be distinguished from pancreatic ductal carcinomas, because even the pancreatobiliary-type ampullary cancers have a much better prognosis than pancreatic ones.
Disclosure/conflict of interest
The authors declare no conflict of interest.
